TARGETING AXONAL LOSS TO FIGHT NEURODEGENERATION

At Proneurotech (PNT) we aspire to develop disease modifying therapeutics to improve the lives of patients and families struggling with neurodegenerative disorders

 

BRINGING EFFECTIVE
TREATMENTS TO PATIENTS

We apply our scientific expertise in molecular genetics, structural biology and medicinal chemistry to target pathways fundamentally involved in axonal loss towards the development of treatments for neurodegenerative diseases.

Our internally enabled biology and chemistry teams work closely to identify, test and advance small molecules to treat neurodegenerative disorders that affect millions of patients and their families worldwide.

 

JOIN OUR EFFORT TO ALLEVIATE THE SUFFERING

PNT is a science-focused neuropharmaceutical company backed by The Column Group. Our team combines research in biochemistry, genetics, neurology, and synthetic chemistry to discover and develop novel neuroprotective drugs that prevent axon degeneration. If you are a smart, passionate and creative individual interested in joining the fight against neurodegeneration please apply to a position below to join our team’s efforts.

Positions Available